John T. Curnutte
2012
In 2012, John T. Curnutte earned a total compensation of $824.2K as Executive Vice President, Research and Development at Portola Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $90,475 |
|---|---|
| Option Awards | $332,716 |
| Salary | $376,980 |
| Other | $23,986 |
| Total | $824,157 |
Curnutte received $377K in salary, accounting for 46% of the total pay in 2012.
Curnutte also received $90.5K in non-equity incentive plan, $332.7K in option awards and $24K in other compensation.
Rankings
In 2012, John T. Curnutte's compensation ranked 6,899th out of 11,487 executives tracked by ExecPay. In other words, Curnutte earned more than 39.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,899 out of 11,487 | 40th |
Division Manufacturing | 2,476 out of 4,253 | 42nd |
Major group Chemicals And Allied Products | 630 out of 1,198 | 47th |
Industry group Drugs | 431 out of 920 | 53rd |
Industry Pharmaceutical Preparations | 337 out of 700 | 52nd |
Source: SEC filing on April 30, 2015.
Curnutte's colleagues
We found two more compensation records of executives who worked with John T. Curnutte at Portola Pharmaceuticals in 2012.